Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Skinbiotherap. (SBTX) Share Price

Price 16.625p on 04-07-2025 at 18:50:08
Change 0.125p 0.76%
Buy 16.75p
Sell 16.50p
Buy / Sell SBTX Shares
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 62,178.00 at 16.6875p
Day's Volume: 2,253,239
Last Close: 16.625p
Open: 16.50p
ISIN: GB00BF33H870
Day's Range 16.50p - 16.625p
52wk Range: 8.50p - 27.50p
Market Capitalisation: £43m
VWAP: 16.62787p
Shares in Issue: 259m

Sector: Medicine and Biotech

Listed In: FTSE AIM All-Share,

Skinbiotherap. (SBTX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 62,178 16.6875p Ordinary
 16:26:28 - 04-Jul-25
Unknown* 500,000 16.70p Negotiated Trade
 16:25:20 - 04-Jul-25
Buy* 100,000 16.63p Ordinary
 16:24:29 - 04-Jul-25
Buy* 14,981 16.6875p Ordinary
 16:18:58 - 04-Jul-25
Buy* 12,000 16.63p Ordinary
 16:15:15 - 04-Jul-25
Unknown* 400,000 16.325p Negotiated Trade
 16:08:26 - 04-Jul-25
Sell* 22,296 16.60p Ordinary
 15:59:33 - 04-Jul-25
Buy* 11,985 16.6875p Ordinary
 15:29:06 - 04-Jul-25
Buy* 5,974 16.7375p Ordinary
 15:23:48 - 04-Jul-25
Buy* 21,000 16.6875p Ordinary
 15:20:54 - 04-Jul-25
See more Skinbiotherap. trades

Skinbiotherap. (SBTX) Share Price History

Time period:
to
Date Open High Low Close Volume
4th Jul 2025 (Fri) 16.50 16.625 16.50 16.625 2,253,239
3rd Jul 2025 (Thu) 16.50 16.80 16.50 16.50 1,884,878
2nd Jul 2025 (Wed) 16.50 16.80 16.50 16.50 227,645
1st Jul 2025 (Tue) 16.50 16.50 16.50 16.50 666,998
30th Jun 2025 (Mon) 16.625 16.80 16.50 16.80 1,255,293
27th Jun 2025 (Fri) 16.625 16.80 16.50 16.80 1,260,075
26th Jun 2025 (Thu) 16.50 16.625 16.50 16.625 2,767,355
25th Jun 2025 (Wed) 16.50 16.50 16.25 16.25 2,051,931
24th Jun 2025 (Tue) 16.625 17.00 16.00 16.00 1,047,890
23rd Jun 2025 (Mon) 16.625 16.625 16.50 16.50 1,466,022
20th Jun 2025 (Fri) 16.625 16.625 16.625 16.625 1,758,958
19th Jun 2025 (Thu) 16.875 16.875 16.625 16.625 397,953
18th Jun 2025 (Wed) 16.625 16.875 16.625 16.875 9,733,417
17th Jun 2025 (Tue) 16.00 16.625 15.75 16.625 3,263,205
16th Jun 2025 (Mon) 17.25 17.625 16.25 16.25 11,005,598
13th Jun 2025 (Fri) 17.625 17.25 17.25 17.25 534,227
12th Jun 2025 (Thu) 17.375 17.625 17.25 17.625 422,350
11th Jun 2025 (Wed) 18.125 18.125 17.375 17.375 990,207
10th Jun 2025 (Tue) 18.375 18.375 18.125 18.125 1,719,475
9th Jun 2025 (Mon) 18.75 18.375 18.25 18.375 1,814,359
6th Jun 2025 (Fri) 18.75 18.75 18.75 18.75 108,754
See more Skinbiotherap. price history

Skinbiotherap. (SBTX) Regulatory News

Date Source Headline
30th Jun 2025 7:00 am RNS Croda Commercial Launch Progressing as Expected
27th Jun 2025 7:00 am RNS Notice of IMC Shareholder Presentation
25th Jun 2025 11:28 am RNS Holding(s) in Company
20th Jun 2025 7:00 am RNS Result of WRAP Retail Offer
16th Jun 2025 2:02 pm RNS WRAP Retail Offer
16th Jun 2025 7:00 am RNS Superdrug agreement, Placing & Retail Offer
22nd May 2025 12:44 pm RNS Correction: Change of Adviser
22nd May 2025 7:00 am RNS Change of advisor
9th May 2025 2:39 pm RNS Holding(s) in Company
9th May 2025 2:30 pm RNS Holding(s) in Company
See more Skinbiotherap. regulatory news

Skinbiotherap. (SBTX) Share News

IN BRIEF: SkinBioTherapeutics raises GBP4 million for Superdrug deal

20th Jun 2025 13:18

SkinBioTherapeutics PLC - Newcastle Upon Tyne, England-based life science firm focused on skin health - Raises GBP4.2 million from the sale of 24.7 million new shares at 17 pence each. This is split between 24.1 million shares sold via placing and subscription, and 587,191 sold in an offer to retail investors. SkinBioTherapeutics announced the equity raise on Monday, saying it is to support an exclusive commercial agreement with Superdrug Stores PLC to roll-out AxisBiotix food supplements across the UK. The supplements are meant to alleviate inflammatory skin conditions. Read More

TRADING UPDATES: SkinBioTherapeutics hails "milestone" Superdrug deal

16th Jun 2025 21:53

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: SkinBioTherapeutics boosts financial 2025 turnover forecast

23rd Oct 2024 16:34

SkinBioTherapeutics PLC - Newcastle, England-based skin health-focused life sciences company - Says the integration of its GBP1.3 million acquisition, Bio-Tech Solutions Ltd, is "well-advanced". It was the company's second acquisition this year, the first being Dermatonics, and the group now has sufficient cash runway to support its operations through to the summer of 2026 without any additional income from its Croda partnership or other joint development agreements. Before the acquisitions, the group projected financial 2024 turnover of around GBP250,000. It now forecasts annualised turnover of GBP6.3 million for financial 2025. Read More

AIM WINNERS & LOSERS: SkinBioTherapeutics and Oxford Metrics make buys

11th Oct 2024 10:38

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday. Read More

AIM WINNERS & LOSERS: SkinBioTherapeutics gets Croda positive feedback

19th Sep 2024 10:54

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

See more Skinbiotherap. news
FTSE 100 Latest
Value8,822.91
Change-0.29

Login to your account

Forgot Password?

Not Registered